The Law Offices of Frank R. Cruz Announces Investigation of Spero Therapeutics, Inc. (SPRO) on Behalf of Investors
businesswire.com
news
2022-06-02 00:00:00

June 02, 2022 05:17 PM Eastern Daylight Time LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Spero Therapeutics, Inc. ('Spero' or the 'Company') (NASDAQ: SPRO) on behalf of investors concerning the Company's possible violations of federal securities laws.



If you are a shareholder who suffered a loss, click here to participate.

On October 28, 2021, Spero announced that it had submitted a New Drug Application ('NDA') to the U.S. Food and Drug Administration ('FDA') for its urinary tract infection treatments, tebipenem HBr.
